Lack of evidence for IgM-induced ADCC: studies with monoclonal and polyclonal antibodies
- PMID: 6788680
- PMCID: PMC1555199
Lack of evidence for IgM-induced ADCC: studies with monoclonal and polyclonal antibodies
Abstract
Different kinds of IgM antibodies were tested for their activity in antibody-dependent cellular cytotoxicity (ADCC): firstly an anti-benzylpenicilloyl (BPO) IgM antibody from immune rabbit serum purified by affinity, ion exchange, and molecular-sieving chromatography, secondly two monoclonal rat anti-BPO IgM antibodies and thirdly a human antidextran antibody prepared from a patient showing restriction of anti-dextran antibodies to the IgM class. Human lymphocytes or purified monocytes served as effector cells. While the two monoclonal rat and the human IgM antibodies showed no ADCC-mediating capacity, ADCC was induced by the rabbit anti-BPO IgM antibody when high antibody concentrations were used. This activity was abolished by further purification using an anti-rabbit IgG (Fc) immunosorbent. The initially observed activity was shown to be likely due to traces of aggregated anti-BPO IgG, which cannot be detected by the methods commonly used. Preincubation of lymphocytes for 24 hr increased the number of EA (IgM)] rosette forming cells but failed to induce IgM-mediated ADCC. Furthermore, evidence for amplification of low-dose IgG-ADCC by IgM could not be found.
Similar articles
-
Synergy between IgG and monoclonal IgM antibodies in antibody-dependent cell cytotoxicity.J Immunol. 1981 Jul;127(1):73-8. J Immunol. 1981. PMID: 6787133
-
Separation of cell-dependent antibody (CDA) and inhibitory antibody by protein-A affinity chromatography and the effect of fractions on antibody-dependent cellular cytotoxicity (ADCC).Immunology. 1979 Mar;36(3):421-6. Immunology. 1979. PMID: 437836 Free PMC article.
-
Induction of mouse IgG2a- and IgG3-dependent cellular cytotoxicity in human monocytic cells (U937) by immune interferon.Cancer Res. 1984 Nov;44(11):5127-31. Cancer Res. 1984. PMID: 6435864
-
Cell-mediated lysis of tumor targets directed by murine monoclonal antibodies of IgM and all IgG isotypes.J Immunol. 1983 Aug;131(2):1028-31. J Immunol. 1983. PMID: 6134771
-
Purification and biochemical characterization of immunotoxins.Cancer Treat Res. 1988;37:323-48. doi: 10.1007/978-1-4613-1083-9_18. Cancer Treat Res. 1988. PMID: 2908631 Review.
Cited by
-
Anti-Gb3 monoclonal antibody inhibits angiogenesis and tumor development.PLoS One. 2012;7(11):e45423. doi: 10.1371/journal.pone.0045423. Epub 2012 Nov 26. PLoS One. 2012. PMID: 23189121 Free PMC article.
-
CD99 is a therapeutic target on disease stem cells in myeloid malignancies.Sci Transl Med. 2017 Jan 25;9(374):eaaj2025. doi: 10.1126/scitranslmed.aaj2025. Sci Transl Med. 2017. PMID: 28123069 Free PMC article.
-
The Functional Role of IgA in the IgM/IgA-Enriched Immunoglobulin Preparation Trimodulin.Biomedicines. 2021 Dec 3;9(12):1828. doi: 10.3390/biomedicines9121828. Biomedicines. 2021. PMID: 34944644 Free PMC article.
-
Antibody-dependent cell-mediated cytotoxicity. Effectors, signals, and mechanisms.Surv Immunol Res. 1983;2(4):327-40. doi: 10.1007/BF02918449. Surv Immunol Res. 1983. PMID: 6606205 No abstract available.
-
IgM response and resistance to ascites tumor growth.Cancer Immunol Immunother. 1987;25(2):87-92. doi: 10.1007/BF00199946. Cancer Immunol Immunother. 1987. PMID: 3664533 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources